OUR MISSION & VALUES
LEVERAGING OUR EXPERTISE AND UNIQUE MARKET
POSITION TO PROVIDE ENHANCED TREATMENT CHOICES
FOR CANADIANS THROUGH NOVEL, SPECIALIZED MEDICINES.
WHAT WE STAND FOR AND ASPIRE TO DRIVES ALL THAT WE DO
We are deeply committed and passionate about improving the lives of Canadians
We strive relentlessly for excellence in specialty treatments
We embrace innovative thinking and practices; as nimble as a start-up with the reassurance that comes from a solid foundation of 40+ years in the industry
We are a business with history and heart—unwaveringly authentic, respectful and persistent
We understand the importance of cultivating partnerships for mutual success
OUR EXPERTISE & HISTORY
A SOLID FAMILY FOUNDATION
Part of the Laboratoire Riva family—a leader in healthcare for close to half a century— Avir is passionate about making a real difference in people’s lives and this is at the root of why we advocate, care, partner and innovate.
FOR CANADIANS BY CANADIANS
Avir is boldly forging a new path in the specialty pharmaceutical market in Canada through the acquisition, in-licensing, co-development and successful commercialization of innovative medicines—providing a much-needed choice in the Canadian therapeutic landscape.
SPECIALTY IS OUR SPECIALIZATION
Avir’s focused approach addresses unmet needs in the Canadian marketplace through a robust pipeline of vital specialty medicines.
INNOVATION WITH PURPOSE
Improving efficiency and choice means investing in new molecules as well as products with unique formats and delivery systems.
LEADING WITH EXPERTISE
Fueled by a seasoned, cross-functional industry team, Avir combines responsiveness with high quality, reliable products and services.
for more information on our sister company, Laboratoire Riva,
a leader in generic medicines in Canada since 1980
OUR LEADERSHIP TEAM & PRESIDENT’S MESSAGE
Avir’s team of passionate professionals has substantial experience in the commercialization of healthcare products within Canada. With deep competencies and knowledge in regulatory, market access, medical, marketing and sales, Avir Pharma is well positioned to bring innovative pharmaceutical products to Canada. At the helm of the Leadership Team are Olivier St-Denis and Kaled Kadri.
Olivier has been the President of both Laboratoire Riva and Avir Pharma since 2013. With close to 20 years of experience in pharmaceutical production and administration, customer service and sales he successfully leads the overall strategic direction and operations of the Avir team.
for a short message from Olivier
Kaled is a highly experienced pharmaceutical executive who has negotiated approximately 50 in-licensing agreements and has successfully launched many new pharmaceutical products in Canada. Kaled’s unique combination of science and business development experience allows him to leverage his expertise and well position Avir Pharma in the Canadian healthcare environment.
May 2, 2019
CRESEMBA™ now available in Canada for the treatment of invasive aspergillosis and invasive mucormycosis
April 10, 2018
Avir Pharma announces the availability of ZEVTERA™ (ceftobiprole medocaril) in Canada
June 14, 2017
Avir Pharma announces distribution agreement with Basilea Pharmaceutica for Cresemba® (isavuconazole)
and Zevtera® (ceftobiprole) in Canada